Return to QS12 Overview

Breast Cancer [QS12]

Measuring the use of this guidance

Statement: 3

People with early breast cancer undergoing breast conserving surgery, which may include the use of oncoplastic techniques, have an operation that both minimises local recurrence and achieves a good aesthetic outcome.

Quality standard measure: Patient satisfaction with outcome of breast surgery.
What was measured: Patients with excellent satisfaction with outcome (mastectomy only)
Data collection end: March 2009
36%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit

Quality standard measure: Patient satisfaction with outcome of breast surgery.
What was measured: Patients with excellent satisfaction with outcome (immediate reconstruction)
Data collection end: March 2009
34%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit

Quality standard measure: Patient satisfaction with outcome of breast surgery.
What was measured: Patients with excellent satisfaction with outcome (delayed reconstruction)
Data collection end: March 2009
47%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit


Statement: 4

People with early breast cancer who are to undergo mastectomy have the options of immediate and planned delayed breast reconstruction discussed with them.

Quality standard measure: Patient satisfaction with discussion about breast surgery options.
What was measured: Proportion of patients who were very satisfied with the options regarding types of breast reconstruction for delayed reconstruction
Data collection end: March 2009
75%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit

Quality standard measure: Patient satisfaction with discussion about breast surgery options.
What was measured: Proportion of patients who were very satisifed with the options regarding types of breast reconstruction for immediate reconstruction
Data collection end: March 2009
71%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit


Statement: 8

People with early invasive breast cancer are involved in decisions about adjuvant therapy after surgery, which are based on an assessment of the prognostic and predictive factors, and the potential benefits and side effects.

Quality standard measure: Patient satisfaction with the decision-making process.
What was measured: Patient with excellent satisfaction with decision making process (delayed reconstruction)
Data collection end: March 2009
87%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit

Quality standard measure: Patient satisfaction with the decision-making process.
What was measured: Patient with excellent satisfaction with decision making process (immediate reconstruction)
Data collection end: March 2009
81%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit

Quality standard measure: Patient satisfaction with the decision-making process.
What was measured: Patient with excellent satisfaction with decision making process (mastectomy only )
Data collection end: March 2009
75%
Area covered: England
Source: National Mastectomy and Breast Reconstruction Audit


Statement: 12

People with recurrent or advanced breast cancer have access to a 'key worker', who is a clinical nurse specialist whose role is to provide continuity of care and support, offer referral to psychological services if required and liaise with other healthcare professionals, including the GP and specialist palliative care services.

Quality standard measure: Patient satisfaction with access to a key worker.
What was measured: Proportion of breast cancer patients who reported being given the name of a Clinical Nurse Specialist who would be in charge of their care
Data collection end: November 2013
93%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with access to a key worker.
What was measured: Proportion of breast cancer patients who reported that they found it easy to contact their Clinical Nurse Specialist
Data collection end: November 2013
71%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with access to a key worker.
What was measured: Proportion of breast cancer patients who reported being given the name of a Clinical Nurse Specialist who would support them through their treatment.
Data collection end: June 2015
92.4%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with access to a key worker.
What was measured: Proportion of breast cancer patients who reported that they found it very or quite easy to contact their Clinical Nurse Specialist.
Data collection end: June 2015
77.2%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with the information, support and signposting provided by the key worker.
What was measured: Proportion of all breast cancer patients who reported that when they had important questions to ask their Clinical Nurse Specialist they got answers they could understand all or most of the time (there was some variation between cancer types but statistical tests indicate that the differences between cancer groups are not significant overall)
Data collection end: November 2013
91%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with the information, support and signposting provided by the key worker.
What was measured: Proportion of breast cancer patients who reported that, when they had important questions to ask their Clinical Nurse Specialist, they got answers they could understand "all of the time".
Data collection end: June 2015
77.8%
Area covered: England
Source: NHS England. National Cancer Patient Experience Survey.



 Return to QS12 Overview